MJardin Group Inc MJARF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.01 / $0.09
- Market Cap
- $90.14
- Volume/Avg
- 1,000 / 1,798
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
MJardin Group Inc is a Canada based cannabis cultivation and management company. It is engaged in the cultivation, processing, and distribution of medical cannabis. The company's operating segment includes Cultivation management in USA and Cultivation operations in Canada. It generates maximum revenue from the Cultivation management in USA segment. Cultivation management in USA segment engaged in the management services to owners of cultivation and dispensary facilities. The services provided are consulting, design, operational, and other management services.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- —
- Website
- https://www.mjardin.com
Valuation
|
Metric
|
MJARF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
MJARF
Financial Strength
|
Metric
|
MJARF
|
|---|---|
Quick Ratio | 0.08 |
Current Ratio | 0.60 |
Interest Coverage | −1.61 |
Quick Ratio
MJARF
Profitability
|
Metric
|
MJARF
|
|---|---|
Return on Assets (Normalized) | −32.98% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −24.06% |
Return on Assets
MJARF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Fxtnpbvhqx | Dzyrft | $69.8 Bil | |
ZTS
| Zoetis Inc Class A | Hdxfbymckp | Qgrn | $68.9 Bil | |
HLN
| Haleon PLC ADR | Jsqhqpyxg | Vxwv | $37.7 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Dbcgljpjp | Wspd | $14.8 Bil | |
VTRS
| Viatris Inc | Srwdcmhz | Ccg | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Dylwgclky | Lstdz | $11.9 Bil | |
CTLT
| Catalent Inc | Ycnthjvb | Txrysn | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Tsdsvkl | Vxwwq | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Tppcxzsvz | Bywjd | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Skhgcxsvy | Pcktfh | $3.5 Bil |